The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns after abiraterone acetate in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Post hoc analysis of COU-AA-302.
 
Thomas W. Flaig
Leadership - Aurora Oncology
Stock and Other Ownership Interests - Aurora Oncology
Honoraria - BN ImmunoTherapeutics; GTx
Consulting or Advisory Role - GTX
Research Funding - Aragon Pharmaceuticals; Bavarian Nordic; Bristol-Myers Squibb; Cougar Biotechnology; Dendreon; Exelixis; GTx; Janssen Oncology; Medivation; Novartis; Pfizer; Roche/Genentech; Sanofi; Sotio; Tokai Pharmaceuticals
Patents, Royalties, Other Intellectual Property - The University of Colorado has filed 2 patents in which I am an inventor. These are related to bladder cancer treatment of early stage disease.
Travel, Accommodations, Expenses - Bavarian Nordic; GTx
 
Matthew R. Smith
Consulting or Advisory Role - Janssen Research & Development
 
Fred Saad
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Novartis; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bavarian Nordic; Janssen Oncology; Millennium; Novartis; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst)
 
Dana E. Rathkopf
Consulting or Advisory Role - Janssen Oncology
Research Funding - Celgene (Inst); Ferring (Inst); Janssen Oncology (Inst); Medivation (Inst); Millennium (Inst); Novartis (Inst); Takeda (Inst)
 
Peter F.A. Mulders
Honoraria - Astellas Pharma; Bayer; Janssen Research & Development
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen Research & Development
Speakers' Bureau - Astellas Pharma; Bayer; Janssen Research & Development
Research Funding - Astellas Pharma; Bayer; Janssen Research & Development
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen Research & Development
 
Eric Jay Small
No Relationships to Disclose
 
Neal D. Shore
Honoraria - Astellas Pharma; Bayer; Dendreon; Ferring; Janssen Research & Development; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Ferring; Janssen Research & Development; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Ferring; Janssen Research & Development; Sanofi
Research Funding - Astellas Pharma; Bayer; Dendreon; Ferring; Janssen Research & Development; Sanofi
 
Karim Fizazi
Honoraria - Amgen; Astellas Pharma; Janssen Research & Development; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen Research & Development; Orion
 
Peter De Porre
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Thian Kheoh
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Jinhui Li
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Mary Beth Todd
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Thomas W. Griffin
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
 
Charles J. Ryan
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - Bayer; Millennium
Research Funding - BIND Biosciences; Karyopharm Therapeutics; Novartis
 
Johann S. De Bono
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Genentech/Roche; Sanofi
Research Funding - AstraZeneca (Inst); Genentech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Genmab; GlaxoSmithKline; Orion; Qiagen; Sanofi; Taiho Pharmaceutical; Vertex